Roman V. Rariy, Ph.D.


roman.rariy.wg10@wharton.upenn.edu Lomonosov Moscow State University, Moscow, Russia B.S., Chemistry, 1993 Ph.D., Chemistry, 1996


Christopher S. A. Reaves


christopher.reaves.wg10@wharton.upenn.edu Duke University, Durham, NC A.B., Magna Cum Laude, Political Science and Economics, 2004


Wonjae Benjamin Rhee


wonjae.rhee.wg10@wharton.upenn.edu Swarthmore College, Swarthmore, PA B.A., High Honors, Biology and Economics, 2004


A leadership role in a biotechnology company.


AstraZeneca, Wilmington, DE MBA Brand Marketing Intern, Summer 2009 Conducted in depth analysis of peer-to-peer promotional program effectiveness for Seroquel XR brand. Recommended segmentation strategies that would result in the higher ROI.


Collegium Pharmaceutical, Cumberland, RI Senior Director, Product Research & Development, 2007-2008 Created product concept and deployed project aimed at $1.2B sleep apnea market. Director, Product Research & Development, 2005-2007


Founded, hired personnel, mentored and supervised 5-member Topical Products group. Developed and launched 7 products with total market value of $25-35M. Manager, Scientific Affairs, 2003-2005 Designed and managed Milnacipran line extension product development programs with total budget exceeding $1.5M.


Project Manager, Scientific Affairs, 2002-2003


Joined company as first full-time employee and worked alongside founders creating company’s vision, raising start-up funds and establishing company’s culture and commercial operations.


The Gillette Company, Needham, MA Research Scientist, Corporate Research & Development, 1999-2002


Massachusetts Institute of Technology, Cambridge, MA


Postdoctoral Associate, Department of Chemistry, 1996-1999


An opportunity to leverage my experiences in strategy consulting, business development and public policy to encourage profound change within the US healthcare system.


Voxiva, Washington, DC Business Development Intern, Spring and Summer 2008


Designed U.S. market entry strategy for global mobile health provider. Supported CEO-led initiative to develop product portfolio addressing diabetes, HIV/AIDS, smoking, obesity, asthma and pandemic influenza.


Richmond Management, New York, NY Richmond Management Venture Fellow, Spring and Summer 2008


Performed market and technological due diligence on mobile health sector. Developed a preliminary investment thesis for mobile health and adjacent markets.


Friends of Fred Thompson, McLean, VA Personal Aide and Analyst, 2007-2008 Supported Senator and senior staff in U.S. presidential campaign. Conducted longitudinal voter survey to identify and microsegment core constituencies. Created outreach tracking database.


The Boston Consulting Group, Atlanta, GA


Consultant, 2007; Associate, 2004-2007 Led client teams to construct entry strategy for $550M health and wellness provider including product design, marketing strategy, and implementation schedule. Assessed multiple acquisition targets for $1B regional health insurer. Eliminated 9% of spend through strategic purchasing for Belgian pharmaceutical client.


An opportunity at a promising healthcare start-up, in healthcare venture capital, or in biopharmaceutical business development or marketing.


Celgene, Summit, NJ MBA Summer Intern – Business Development, Summer 2008


Performed due diligence for potential M&A and licensing transactions for oncology and inflammation therapeutic areas, including valuation assessments using discounted cash flow and NPV analyses. Performed market analysis and created multiple financial models, including one for a potential $2B+ transaction.


Accenture, Philadelphia, PA Analyst, 2004-2006, Consultant, 2006-2008


Significant experience improving R&D business processes, including clinical trial management, clinical data man- agement, and regulatory submissions, for multiple top 10 global pharmaceu- tical companies. Led international team of executives to develop a new R&D strategy, project management model and project management organization. Designed and imple- mented program management tools and governance for joint-venture Medical Affairs team of blockbuster drug, resulting in faster decision- making and on-time execution of 2007 Competitive Medical Plan. Developed risk-based budget allocation model for ~$3B of R&D spending for major pharmaceutical company. Directed Philadelphia office and project- based “Great Place to Work” initiatives to improve coworker relationships through networking and mutual learning opportunities.


21


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40